What biohit.fi does

Biohit Oyj is a Finnish biotechnology company headquartered in Helsinki, founded in 1988, and publicly listed on the NASDAQ OMX Helsinki Small Cap exchange under ticker BIOBV. The company is organised around gastrointestinal diagnostics, developing biomarker-based blood tests, point-of-care rapid tests, and laboratory assays built around proprietary biomarker panels. Its core product portfolio includes GastroPanel, a blood-based biomarker test for atrophic gastritis and Helicobacter pylori screening; GastroPanel Quick Test NT, a 20-minute finger-prick rapid test; Acetium, a consumer-facing L-cysteine-based acetaldehyde-binding product positioned for smoking-related and alcohol-related use; ColonView, a FIT-based colorectal cancer screening test; plus ancillary tests for calprotectin, vitamin B12, vitamin D, celiac disease, and H. pylori. The company also supplies monoclonal antibodies for research use, the GP Reader NT benchtop instrument, and GastroSoft interpretation software.

The business model is dual-channel. B2B revenue is generated through the sale of diagnostic test kits, laboratory instruments, and software to hospitals, health centres, and clinical laboratories, supported by clinical validation evidence including the published Oulu study and a publicly cited €42 million estimated Finnish healthcare-savings figure tied to preventive screening. B2C revenue is generated through over-the-counter sale of Acetium capsules and adjacent consumer health products via a proprietary e-commerce storefront. Distribution is executed through wholly-owned subsidiaries in the United Kingdom and Italy combined with a global network of independent distributors. All in-scope medical devices are CE-marked under EU regulatory frameworks, and the company operates under GDPR-compliant data practices.

Operationally, the company participates in industry trade shows including WHX Labs Dubai 2026 and references an annual report for 2025, indicating continued commercial activity but providing no quantitative revenue, headcount, or unit-volume data in the input. Technology infrastructure described is conventional (Google Analytics, Salesforce, Giosg) with no disclosed AI/ML components in either the diagnostic or consumer product lines.

Name

biohit.fi

Legal name

Biohit Oyj

Website

https://biohit.fi

Company type

Public

Founded year

1988

Operating status

Operating

Short description

Biohit Oyj is a Finnish biotechnology company developing gastrointestinal diagnostic tests, biomarker-based blood assays, and acetaldehyde-binding consumer health products for healthcare providers, laboratories, and consumers via subsidiaries in Finland, the UK, and Italy.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Pharmaceutical Preparation Manufacturing (325412)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Gastrointestinal & Digestive Health (HLAIADAD)

Keywords

• Gastrointestinal diagnostics
• In vitro diagnostics
• Medical device manufacturing
• Biomarker testing kits
• Acetaldehyde binding products

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Test Kits: Sale of ELISA-based laboratory tests and rapid diagnostic test kits for gastrointestinal conditions including GastroPanel, H. pylori tests, celiac tests, calprotectin, and vitamin D/B12 tests. Sold to healthcare professionals and institutions.
2. Medical Devices (Acetium®): Sale of Acetium® medical devices (capsules and lozenges) containing L-cysteine for stomach protection and smoking cessation. Distributed through pharmacies, e-commerce (Biohitshop), and supermarkets.
3. Laboratory Instruments: Sale and supply of laboratory equipment including GP Reader NT for reading diagnostic test results.
4. Monoclonal Antibodies: Sale of research-use monoclonal antibodies covering extracellular matrix components, cytoskeletal proteins, neurotransmitters, and gastric biomarkers.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Biohit Oyj develops, manufactures, and sells in vitro diagnostic test kits and laboratory instruments for gastrointestinal and gastric disease detection, including the GastroPanel® multi-biomarker panel for atrophic gastritis and H. pylori screening, rapid point-of-care tests for celiac disease, colorectal cancer (ColonView® FIT), calprotectin, vitamins B12 and D, lactose intolerance, and H. pylori biopsy testing. The company also sells CE-marked Acetium® medical-device capsules and lozenges that use a slow-release L-cysteine formulation to bind carcinogenic acetaldehyde in the stomach or saliva for gastric protection and smoking cessation, plus a research-use monoclonal antibody catalogue and the GastroSoft™ decision-support software and GP Reader NT instrument.

Differentiator

Problem solved

Functional benefit

Brands

• GastroPanel®: Diagnostic test panel for gastric mucosal assessment including pepsinogen I, pepsinogen II, gastrin-17, and H. pylori IgG antibodies
• Acetium®
• ColonView®
• GastroSoft™
• GP Reader NT

Products and services

• GastroPanel® quick test NT Rapid point-of-care test that measures gastric biomarkers (pepsinogen I, pepsinogen II, gastrin-17) and H. pylori IgG antibodies from a finger-prick blood sample to detect atrophic gastritis and H. pylori infection in approximately 20 minutes, intended for healthcare professionals.
• GastroPanel® Unified ELISA Enzyme-linked immunosorbent assay (ELISA) based test for comprehensive detection of H. pylori infection and atrophic gastritis using serum biomarkers, used by hospital and reference laboratories.
• GastroSoft™ Decision-support software application for healthcare professionals that analyzes GastroPanel® test results against reference values and generates detailed diagnostic reports, including a flowchart presenting eight different biomarker profiles with interpretations.
• GP Reader NT Laboratory instrument designed for reading and analyzing diagnostic test results from Biohit's rapid test portfolio, used in clinical and point-of-care settings.
• BIOHIT Active B12 (HoloTC) ELISA-based vitamin test that accurately measures active B12 vitamin (holotranscobalamin) concentration in serum for diagnosis and monitoring of B12 deficiency in laboratory settings.
• BIOHIT Total 25OH Vitamin D ELISA test for measuring total 25-hydroxyvitamin D levels in serum for assessment of vitamin D status in laboratory settings.
• BIOHIT Calprotectin ELISA-based test for measuring calprotectin levels, a marker of intestinal inflammation used in inflammatory bowel disease diagnostics in clinical laboratories.
• BIOHIT ColonView® quick test (FIT) Fecal immunochemical test (FIT) for detecting occult blood in stool samples, designed for colorectal cancer screening; detects both hemoglobin (Hb) and hemoglobin/haptoglobin complex (Hb/Hp) as indicators of colorectal neoplasia, used in clinical and screening settings.
• BIOHIT Celiac quick test Qualitative point-of-care immunochromatographic in vitro test for detecting tissue transglutaminase antibodies (tTG IgA/IgG/IgM) in whole blood, plasma, or serum samples for celiac disease diagnosis, providing results in 10 minutes.
• BIOHIT Helicobacter pylori UFT300 Innovative ureaase-based rapid test for H. pylori detection from biopsy samples during gastroscopy; available in cup and plate versions with positive results in approximately 5 minutes and full confirmation within 5 minutes.
• Helicobacter pylori quick test Rapid diagnostic tool used during gastroscopy to detect H. pylori bacteria directly from gastric tissue biopsy samples; positive results appear within minutes and negative results are confirmed within 30 minutes.
• Lactose Intolerance quick test Rapid test for diagnosing lactase hypolactasia from duodenal biopsy samples during gastroscopy; measures lactase enzyme activity with results in approximately 20 minutes.
• Acetium® lozenge Nicotine-free lozenge containing L-cysteine that binds acetaldehyde in saliva; classified as a CE-marked medical device for smoking cessation and acetaldehyde reduction, sold over the counter to consumers.
• Acetium® capsule CE-marked medical device containing 100 mg L-cysteine per capsule that binds acetaldehyde in the stomach; designed for individuals with atrophic gastritis, PPI users, or chronic H. pylori infection to reduce carcinogenic acetaldehyde exposure, sold over the counter to consumers.
• BIOHIT FAEX® Sample System Sample collection and handling system (FAEX®) for laboratory diagnostic testing workflows, used by clinical laboratories.
• Monoclonal Antibodies (research portfolio) Portfolio of research-use monoclonal antibodies covering human extracellular matrix components, spectrins, cytoskeletal polypeptides, neurotransmitter substances, gastric biomarkers, endothelial cell surface markers, phytoestrogen genistein, and integrins for research and laboratory applications.

Quantifiable outcome

• GastroPanel test showed 92.4% agreement with gastroscopy findings in Oulu University Hospital study (n=522)
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Biohit HealthCare Ltd (UK)coreOthersWholly-owned subsidiary based in Ellesmere Port, Cheshire, UK. Handles direct sales, distribution, and customer service for Biohit products in the United Kingdom market. Tel: +44 0151 550 4 550.
• Biohit HealthCare Srl (Italy)coreOthersWholly-owned subsidiary based in Pero (Milano), Italy. Handles direct sales, distribution, and customer support for Biohit products in the Italian market. Tel: +39 02 38238113.
• International Distributor/Partner NetworkminorChannel Partner/ Reseller/ DistributorBiohit works with authorised distributors globally across multiple regions. The company actively seeks new distribution and licensing partners. An inquiry form on their website covers 15+ product lines for prospective distributors interested in specific regions.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Bio-Rad Laboratories: Global life science and clinical diagnostics company that manufactures ELISA-based immunoassay kits, quality controls, and diagnostic instruments. Overlaps directly with Biohit's GastroPanel ELISA platform, calprotectin testing, and laboratory instrument portfolio across the same hospital and laboratory customer base.
• EKF Diagnostics: UK-headquartered point-of-care diagnostics company with a portfolio of rapid tests, ELISA kits, and laboratory analyzers serving gastrointestinal, infectious disease, and women's health. Comparable to Biohit's rapid test kits (H. pylori, celiac, lactose intolerance) and centralized instrument-reader model.
• Meridian Bioscience: US-based diagnostics company focused on gastrointestinal infectious disease testing, including H. pylori and C. difficile assays. Directly comparable to Biohit's H. pylori UFT300 rapid urease test and broader GI infectious disease diagnostic franchise.
• R-Biopharm: German diagnostics company offering ELISA and rapid tests for gastrointestinal infections (H. pylori, celiac, calprotectin) and clinical chemistry. Closely comparable niche GI diagnostics portfolio with similar customer base of hospitals and clinical laboratories across Europe.

Broad incumbents

• DiaSorin: Italian-headquartered global IVD company with a specialty immunoassay menu on its LIAISON platforms, including vitamin D and B12 assays that overlap Biohit's Active B12 and Total 25OH Vitamin D ELISA products. A larger established competitor serving the same clinical laboratory channel.
• QuidelOrtho: Large US-based diagnostics company offering rapid immunoassays, ELISA systems, and specialty diagnostics including H. pylori testing. Comparable in rapid test technology and clinical diagnostic menu though serving a much broader portfolio of indications and geographies.
• Abbott Diagnostics: Global IVD leader with extensive immunoassay menu on ARCHITECT and Alinity platforms including H. pylori, celiac, B12, and vitamin D tests. Represents the scale incumbent whose bundled hospital contracts and broad menu could compete with Biohit's narrower specialty GI offering.
• Roche Diagnostics: World's largest IVD company offering comprehensive immunoassay, clinical chemistry, and molecular diagnostic menus. Comparable through overlapping ELISA-based biomarker testing and laboratory instrument platforms, though as part of a vastly broader diagnostic portfolio.

Regional players

• Aidian (formerly Medix Biochemica): Finnish IVD company specializing in clinical chemistry and immunoassay tests for point-of-care and laboratory use. Comparable as a fellow Finnish diagnostics specialist serving overlapping European clinical laboratory customers with similar ELISA-based test menus.

Emerging players

• Hologic (Diagnostics): US diagnostics and women's health company with growing specialty immunoassay menu including gastrointestinal markers. Partial overlap with Biohit's biomarker panel strategy through clinical laboratory testing channels, particularly in women's health-adjacent diagnostics.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/biohit
• Facebookfacebook.com/biohitoyj
• LinkedInlinkedin.com/company/biohit-oyj
• Instagraminstagram.com/biohit_oyj

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biohit.fi